Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection

Journal of General Virology

Volumn 77, Issue 6, 1996, Pages 1239-1248

  Gaddum, Ruth M ^a   Cook, Roy S ^a   Wyld, Sara G ^a   López, Juan A ^b   Bustos, Regla ^b   Melero, José A ^b   Taylor, Geraldine ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN RESPIRATORY SYNCYTIAL VIRUS; RESPIRATORY SYNCYTIAL VIRUS; SYNCYTIAL VIRUS; VACCINIA; VACCINIA VIRUS; ANIMALIA;

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MUTANT PROTEIN; NEUTRALIZING ANTIBODY; PHENYLALANINE; SERINE; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINATION; VACCINIA VIRUS; VIRUS RECOMBINANT; VIRUS RESISTANCE;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HN PROTEIN; HUMANS; LUNG; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0029886753     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-6-1239     Document Type: Article

References (44)

1. ALWAN, W. H. & OPENSHAW, P. J. M. (1993). Distinct patterns of T-and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine 11, 431-437
2. + T cells. Clinical and Experimental Immunology 88, 527-536.
3. ALWAN, W. H., KOZLOWSKA, W. J. & OPENSHAW, P. J. M. (1994). Distinct types of lung disease caused by functional subsets of antiviral T cells. Journal of Experimental Medicine 179, 81-89.
4. BENNINK, J. R. & YEWDELL, J. W. (1990). Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. Current Topics in Microbiology and Immunology 163, 155-183.
5. CANNON, M. J., STOTT, E. J., TAYLOR, G. & ASKONAS, B. A. (1987). Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology 62, 133-138.
6. CANNON, M. J., OPENSHAW, P. J. M. & ASKONAS, B. A. (1988). Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. Journal of Experimental Medicine 168, 1163-1168.
7. CHERRIE, A. H., ANDERSON, K., WERTZ, G. W. & OPENSHAW, P. J. M. (1992). Human cytotoxic T cells stimulated by antigen on dendritic cells recognise the N, SH, F, M, 22K and 1b proteins of respiratory syncytial virus. Journal of Virology 66, 2102-2110.
8. CONNORS, M., COLLINS, P. L., FlRESTONE, C.-Y. & MURPHY, B. R. (1991). Respiratory syncytial virus (RSV) F, G, M2 (22K.) and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. Journal of Virology 65, 1634-1637.
9. + T cells while that induced by Vac-F or Vac-G recombinants is mediated by antibodies. Journal of Virology 66, 1277-1281.
10. + T cells. Journal of Virology 66, 7444-7451.
11. CONNORS, M., GIESE, N. A., KULKARNI, A. B., FIRESTONE, C.-Y., MORSE, H. C., III & MURPHY, B. R. (1994). Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. Journal of Virology 68, 5321-5325.
12. DEL VAL, M., SCHLICHT, H.-J., VOLKWER, H., MESSERLE, M., REDDEHASE, M. J. & KOSZINOWSKI, W. H. (1991). Protection againt lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. Journal of General Virology 65, 3641-3646.
13. DENNY, F. W., TAYLOR-ROBINSON, D. & ALLISON, A. C. (1972). The role of the thymus-dependent immunity in Mycoplasma pulmonis infections of mice. Journal of Medical Microbiology 5, 327-335.
14. FERNIE, B. F., FORD, E. C. & GERIN, J. L. (1981) The development of BALB/c cells persistently infected with respiratory syncytial virus: presence of ribonucleoprotein on the cell surface. Proceedings of the Society for Experimental Biology and Medicine 167, 83-86.
15. FULGINITI, V. A., ELLER. J. J., SIEBER, O. F., JOYNER. J. W., MINAMITANI, M. & MEIKLEJOHN, G. (1969). Respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum precipitated respiratory syncytial virus vaccine. American Journal of Epidemiology 89, 435-448.
16. GARCÍA-BARRENO, B., JORCANO, J. L , AUKENBAUER, C., LÓPEZ-GALINDEZ, C. & MELERO, J. A. (1988). Participation of cytoskeletal intermediate filaments in the infectious cycle of human respiratory syncytial virus (RSV). Virus Research 9, 307-322.
17. GARCÍA-BARRENO, B , PALOMO, C., PEÑAS, C., DELGADO, T., PEREZBRENA, P. & MELERO, J. A. (1989). Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. Journal of Virology 63, 925-932.
18. HALL, C. B., DOUGLAS, R. G., JR & GEIMAN, J. M. (1976). Respiratory syncytial virus infections in infants: quantitation and duration of shedding. Journal of Pediatrics 89, 11-15.
19. HANY, M., OEHEN, S., SCHULZ, M., HENGARTNER, H., MACKETT, M., BISHOP, D. H. L., OVERTON, H & ZINKERNAGEL, R. M. (1989). Antiviral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. European Journal of Immunology 19, 417-424.
20. KIM, H. W., CANCHOLA, J. G., BRANDT, C. D., PYLES, G., CHANOCK, R. M., JENSEN, K. & PARROTT, R. H. (1969). Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89, 422-434.
21. KIMMAN, T. G. & WESTENBRINK, F. (1990). Immunity to human and bovine respiratory syncytial virus. Archives of Virology 112, 1-25.
22. LAWSON, C. M., BENNINK, J R., RESTIFIO, N P., YEWDELL, J W. & MURPHY, B. R. (1994). Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. Journal of Virology 68, 3505-3511.
23. 1 subunit of human respiratory syncytial virus F glycoprotein blocks its cell surface transport at an early stage of the exocytic pathway. Journal of General Virology 77, 649-660.
24. MCINTOSH, K. & CHANOCK, R. M. (1990). Respiratory syncytial virus. In Virology, pp. 1045-1072. Edited by B. N. Fields & D. M. Knipe. New York: Raven Press
25. NICHOLAS, J., RUBINO, K., LEVELY, M., ADAMS, E. & COLLINS, P. (1990). Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins. Journal of Virology 64, 4232-4241.
26. OLMSTED, R. A., ELANGO, N. & PRINCE, G. A. (1986). Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proceedings of the National Academy of Sciences, USA 83, 7462-7466.
27. OPENSHAW, P. J. M., PEMBERTON, R. M., BALL. L. A., WERTZ, G. W. & ASKONAS, B. A. (1988). Helper T cell recognition of respiratory syncytial virus in mice. Journal of General Virology 69, 305-312.
28. d-restricted cytotoxic T lymphocytes from mice primed by infection. Journal of Virology 64, 1683-1689.
29. OPENSHAW, P. J. M., CLARKE, S. L. & RECORD, F. M. (1992). Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitised to the major surface glycoprotein G. International Immunology 4, 493-500.
30. PEMBERTON, R. M., CANNON, M. J., OPENSHAW, P. J. M., BALL, L A., WERTZ, G. W. & ASKONAS, B. A. (1987). Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. Journal of General Virology 68, 2177-2182.
31. PRINCE, G. A., JENSON, A. B., HEMMING, V. G., MURPHY, B. R., WALSH, E. E., HORSWOOD, R. L. & CHANOCK, R. M. (1986). Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. Journal of Virology 57, 721-728.
32. PRINGLE, C. (1987). Paramyxoviruses and diseases. In Molecular Basis of Virus Diseases, pp. 51-90. Edited by W. C. Russell & J. W. Almond. Cambriage: Cambridge University Press.
33. RAMMENSEE, H.-G., FRIEDE, T. & STEVANOVIC, S. (1995). MHC ligands and peptide motifs: first listing. Immunogenetics 41, 178-228.
34. STOTT, E. J. & TAYLOR, G. (1985). Respiratory syncytial virus. Archives of Virology 84, 1-52
35. STOTT, E. J., TAYLOR, G., BALL, L. A., ANDERSON, K., YOUNG, K. K. Y., KING, A. M. Q. & WERTZ, G. W. (1987). Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. Journal of Virology 61, 3855-3861.
36. TAYLOR, G. (1994). The role of antibody in controlling and clearing virus infections. In Strategies in Vaccine Design, pp. 17-34. Edited by G. L. Ada Austin: R. G. Landes.
37. TAYLOR, G., STOTT, E. J., BEW, M., FERNIE, B. F., COTE, P. J., COLLINS, A. P., HUGHES, M. & JEBBETT, J. (1984). Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52, 137-142.
38. TAYLOR, G., STOTT, E. J. & HAYLE, A. J. (1985). Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus. Journal of General Virology 66, 2533-2538.
39. TAYLOR, G., STOTT, E. J., FURZE, J., FORD, J. & SOPP, P. (1992). Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies. Journal of General Virology 73, 2217-2223.
40. TEMPEST, P. R., BREMNER, P., LAMBERT, M., TAYLOR, G., FURZE, J. M., CARR, F. J. & HARRIS, W. J. (1991). Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo. Bio/Technology 9, 266-271.
41. TOWBIN, H., STAEHELIN, T. & GORDON, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets of procedure and some applications. Proceedings of the National Academy of Sciences, USA 76, 4350-4354.
42. VAUX-PERETZ, F. & MEIGNIER, B. (1990) Comparison of lung histology and bronchoalveolar lavage cytology in mice and cotton rats infected with respiratory syncytial virus. Vaccine 8, 543-547.
43. WALSH, E. E., SCHLESINGER, J. J. & BRANDRISS, M. W. (1984). Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infection and Immunity 43, 756-758.
44. ZINKERNAGEL, R. M. & WELSH, R. M. (1976). H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. Journal of Immunology 117, 1495-1502.